MarkJHamblinMD
Pulmonology • Kansas City, KSCritical Care Medicine, Interstitial Lung Diseases, Pleural Disease, Restrictive Lung Disease
Assistant Professor, Internal Medicine, University Kansas School of Medicine
Dr. Hamblin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4000 Cambridge St
Kansas City, KS 66160Phone+1 913-588-1227- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
Tulane UniversityResidency, Internal Medicine, 2003 - 2007
University of Missouri-Columbia School of MedicineClass of 2003
Certifications & Licensure
MO State Medical License 2021 - 2025
KS State Medical License 2011 - 2024
LA State Medical License 2004 - 2008- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
- Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial Start of enrollment: 2020 Dec 17
Roles: Contact
- Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 12 citationsA Phase IIb Randomized Clinical Study of an Anti-αβMonoclonal Antibody in Idiopathic Pulmonary Fibrosis.Ganesh Raghu, Majd Mouded, Daniel C Chambers, Fernando J Martinez, Luca Richeldi, Lisa H Lancaster, Mark J Hamblin, Kevin F Gibson, Ivan O Rosas, Antje Prasse, Guolin ...> ;American Journal of Respiratory and Critical Care Medicine. 2022 Nov 1
- 14 citationsLong-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extensio...Ganesh Raghu, Mark J Hamblin, A Whitney Brown, Jeffrey A Golden, Lawrence A Ho, Marlies S Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E Antin-Ozerkis, Keith ...> ;Respiratory Research. 2022 May 21
- 26 citationsDiagnosis, course and management of hypersensitivity pneumonitis.Mark Hamblin, Helmut Prosch, Martina Vašáková> ;European Respiratory Review. 2022 Mar 31
- Join now to see all
Hospital Affiliations
The University of Kansas HospitalKansas City, Kansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
